-
Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020
- Zacharoula Bogogiannidou1 , Alexandros Vontas1 , Katerina Dadouli1 , Maria A Kyritsi1 , Soteris Soteriades1 , Dimitrios J Nikoulis1 , Varvara Α Mouchtouri1 , Michalis Koureas1 , Evangelos I Kazakos2 , Emmanouil G Spanos1 , Georgia Gioula3 , Evangelia E Ntzani4,5,6 , Alexandros A Eleftheriou4 , Alkiviadis Vatopoulos7 , Efthimia Petinaki8 , Vassiliki Papaevangelou9 , Matthaios Speletas10 , Sotirios Tsiodras11 , Christos Hadjichristodoulou1
-
View Affiliations Hide AffiliationsAffiliations: 1 Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, Larissa, Greece 2 Faculty of Midwifery, School of Health Sciences, University of Western Macedonia, Kozani, Greece 3 National Influenza Reference Laboratory for Northern Greece, Microbiology Department, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece 4 Department of Hygiene and Epidemiology, University of Ioannina Faculty of Medicine, Ioannina, Greece 5 Center for Evidence Synthesis in Health, Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, United States 6 Institute of Biosciences, University Research Center of loannina, Ioannina, Greece 7 Department of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece 8 Department of Microbiology, University Hospital of Larissa, University of Thessaly, Larissa, Greece 9 Third Department of Paediatrics, National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece 10 Department of Immunology and Histocompatibility, Faculty of Medicine, University of Thessaly, Larissa, Greece 11 Fourth Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, GreeceChristos Hadjichristodoulouxhatzi uth.gr
-
View Citation Hide Citation
Citation style for this article: Bogogiannidou Zacharoula, Vontas Alexandros, Dadouli Katerina, Kyritsi Maria A, Soteriades Soteris, Nikoulis Dimitrios J, Mouchtouri Varvara Α, Koureas Michalis, Kazakos Evangelos I, Spanos Emmanouil G, Gioula Georgia, Ntzani Evangelia E, Eleftheriou Alexandros A, Vatopoulos Alkiviadis , Petinaki Efthimia, Papaevangelou Vassiliki, Speletas Matthaios, Tsiodras Sotirios, Hadjichristodoulou Christos. Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020. Euro Surveill. 2020;25(31):pii=2001369. https://doi.org/10.2807/1560-7917.ES.2020.25.31.2001369 Received: 12 Jul 2020; Accepted: 03 Aug 2020
Abstract
A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estimated at 0.02% and 0.25%, respectively, in March and April, infection fatality rate at 2.66% and 0.54%. Our findings confirm low COVID-19 incidence in Greece and possibly the effectiveness of early measures.
Article metrics loading...
Full text loading...
References
-
Greek Ministry of Education and Religious Affairs. 10-03-20 Προσωρινή απαγόρευση της εκπαιδευτικής λειτουργίας όλων των εκπαιδευτικών δομών [Temporary ban on the operation of all educational structures].Athens: Greek Ministry of Education and Religious Affairs; 10 Mar 2020. Greek. Available from: https://www.minedu.gov.gr/news/44308-10-03-20-prosorini-apagorefsi-tis-ekpaideftikis-leitourgias-olon-ton-ekpaideftikon-domon
-
European Union Agency for Fundamental Rights (FRA). Coronavirus COVID-19 outbreak in the EU Fundamental Rights Implications. Vienna: FRA; 23 Mar 2020. Available from: https://fra.europa.eu/sites/default/files/fra_uploads/greece-report-covid-19-april-2020_en.pdf
-
National Public Health Organization (NPHO). Hμερήσια έκθεση επιδημιολογικής επιτήρησηςλοίμωξης από το νέο κορωνοϊό (COVID-19) Δεδομένα έως 30 Aπριλίου 2020. [Daily report of epidemiological surveillance of new coronavirus disease (COVID-19). Data until 30 April 2020]. Marousi: NPHO; 2020. Greek. Available from: https://eody.gov.gr/wp-content/uploads/2020/04/covid-gr-daily-report-20200430.pdf
-
European Centre for Disease Prevention and Control (ECDC). COVID-19 situation update for the EU/EEA and the UK, as of 11 July 2020. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea
-
Nardone A, Miller E, ESEN2 Group. Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2). Euro Surveill. 2004;9(4):5-7. https://doi.org/10.2807/esm.09.04.00456-en PMID: 15192256
-
Naing NN. Easy way to learn standardization : direct and indirect methods. Malays J Med Sci. 2000;7(1):10-5. PMID: 22844209
-
Bendavid E, Mulaney B, Sood N, Shah S, Ling E, Bromley-Dulfano R, et al. COVID-19 antibody seroprevalence in Santa Clara County, California. medRxiv 2020.04.14.20062463. https://doi.org/10.1101/2020.04.14.20062463
-
MacMahon B, Trichopoulos D. Epidemiology: principles and methods: Boston: Little, Brown and Company; 1996.
-
Diggle PJ. Estimating prevalence using an imperfect test. Epidemiol Res Int. 2011;2011:608719. https://doi.org/10.1155/2011/608719
-
Campbell I. Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Stat Med. 2007;26(19):3661-75. https://doi.org/10.1002/sim.2832 PMID: 17315184
-
Our World in Data. Daily COVID-19 tests per thousand people -Greece Oxford: University of Oxford; 2020. Available from: https://ourworldindata.org/coronavirus-testing#greece
-
World Health Organization (WHO). Population-based age-stratified seroepidemiological investigation protocol for COVID-19 virus infection, 17 March 2020. Geneva: WHO; 2020. Available from: https://apps.who.int/iris/handle/10665/331656
-
Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020.
-
Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;S0140-6736(20)31304-0. Ahead of print.
-
European Centre for Disease Prevention and Control (ECDC). COVID-19 surveillance report. Stockholm: ECDC; 2020. [Accessed: 10 July 2020]. Available from: https://covid19-surveillance-report.ecdc.europa.eu/#age-sex-pyramids
-
World Health Organization (WHO). Transmission of SARS-CoV-2: implications for infection prevention precautions. Geneva: WHO; 9 Jul 2020. Available from: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions
Data & Media loading...